Nordion Inc (NDN.TO)

BUY
Had a tough year, but likes. Has a lot of good prospects.
BUY
Has good assets. Hold for the long term.
DON'T BUY
Has good biotech assets, but fully valued now.
HOLD
Prefers buying at $15/16. Sell in the low $20's.
TOP PICK
A conservative way to get into proteomics and biotechs.
DON'T BUY
Prefers to buy in the lower teens.
BUY
Likes the diversity of biotechs. A good buy.
DON'T BUY
Not a fan at this time. Sell at $22/22.50.
TOP PICK
Good fundamentals.
STRONG BUY
Top choice in Canada for biotech sector.
DON'T BUY
Growth has been disappointing. Too high a price.
BUY
Has earnings and positive cash flow.
DON'T BUY
Best Canadian health market play. A lot of government regulation so could be cut back. Prefers US company.
TOP PICK
(Was a top pick on July 24 up 10%) Well diversified. Generates good cash flow.
BUY
Likes.
Showing 121 to 135 of 229 entries